Mihalis Verykokakis Research Group

2023: Transcriptional control of cell fate decisions during innate T cell development
  Seminar Series, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

2022: Transcriptional control of Natural Killer T cell development
   Annual Conference of the Hellenic Society of Physiology, Athens, Greece

2021: Transcriptional control of innate T cell development
  Seminar Series, University of Sussex, Brighton, UK

2021: Understanding the function of BCL6 in innate T cell development
  Seminar Series, University of Cyprus, Nicosia, Cyprus

2019: Rare immune cell types
  Lecturer, 2nd Immunology Workshop for Clinicians, Heraklion Crete

2019: The transcription factor BCL6 controls early development of innate-like T cells
  Short Talk, EMBO Workshop on CD1-MR1: Beyond MHC restricted Lymphocytes, Oxford, UK

2019: The transcription factor BCL6 controls early development of innate-like T cells
  Selected talk, FASEB 2019 – The Molecular Mechanisms of Immune Cell and Function

2017: Transcriptional regulation of innate T cell development
  Invited Speaker, 39th Scientific Conference, Greek Society for the Biological Sciences, Lamia, Greece

2015: The transcription factor LEF1 controls invariant natural killer T cell expansion and Th2-type effector differentiation
  Short talk, 66th Congress of the Hellenic Society of Biochemistry and Molecular Biology, Athens, Greece

2015: The E/ID proteins regulate the NKT2 cell fate through LEF1
  Short talk, CD1-MR1 Meeting 2015, Mantra Lorne, Victoria, Australia